Muneaki Fujimoto - Japan Tobacco Executive Officer, Director of Medicine Business
| JAPAY Stock | USD 13.63 0.10 0.74% |
Director
Muneaki Fujimoto is Executive Officer, Director of Medicine Business of Japan Tobacco ADR since 2012.
| Tenure | 12 years |
| Phone | 81 3 6636 2914 |
| Web | https://www.jt.com |
Japan Tobacco Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.12 %, meaning that it generated $0.12 on every $100 dollars invested by stockholders. Japan Tobacco's management efficiency ratios could be used to measure how well Japan Tobacco manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Luc Jobin | British American Tobacco | 61 | |
| Hae Kim | British American Tobacco | 50 | |
| Alan Davy | British American Tobacco | 55 | |
| Susan Farr | British American Tobacco | 64 | |
| Tadeu Marroco | British American Tobacco | 57 | |
| Werner Geissler | Philip Morris International | 67 | |
| Lennart Freeman | Universal | 69 | |
| Jerome Abelman | British American Tobacco | 59 | |
| Johan Vandermeulen | British American Tobacco | 56 | |
| Johan Vandermeulen | British American Tobacco | 55 | |
| Thomas Johnson | Universal | 70 | |
| Michael Lawton | Universal | 61 | |
| Dessislava Temperley | Philip Morris International | 48 | |
| Holly Koeppel | British American Tobacco | 62 | |
| Gregory Baxter | Turning Point Brands | 67 | |
| Eddie Moore | Universal | 71 | |
| Ashley Frushone | Turning Point Brands | 46 | |
| Peter Durman | Imperial Brands PLC | N/A | |
| Theodore Broome | Universal | 70 | |
| Arnold Zimmerman | Turning Point Brands | 83 | |
| Lisa Hook | Philip Morris International | 63 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0589 |
Japan Tobacco ADR Leadership Team
Elected by the shareholders, the Japan Tobacco's board of directors comprises two types of representatives: Japan Tobacco inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Japan. The board's role is to monitor Japan Tobacco's management team and ensure that shareholders' interests are well served. Japan Tobacco's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Japan Tobacco's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kazuhito Yamashita, Executive Officer | ||
| Masamichi Terabatake, President Executive President CEO, Representative Director | ||
| Nobuya Kato, VP CFO | ||
| Kiyohide Hirowatari, Chief Legal Officer and Sr. VP | ||
| Mutsuo Iwai, Senior Managing Executive Officer | ||
| Naohiro Minami, CFO and Sr. VP | ||
| Muneaki Fujimoto, Executive Officer, Director of Medicine Business | ||
| Osamu Hirose, Sr Counsel | ||
| Junichi Fukuchi, Executive Officer, Manager of Business Planning Office in Main Tobacco Business Unit | ||
| Dinesh Thotakura, Gen Division |
Japan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Japan Tobacco a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 37.17 B | |||
| Shares Outstanding | 3.55 B | |||
| Price To Earning | 11.74 X | |||
| Price To Book | 1.33 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 2.32 T |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Japan Pink Sheet Analysis
When running Japan Tobacco's price analysis, check to measure Japan Tobacco's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Japan Tobacco is operating at the current time. Most of Japan Tobacco's value examination focuses on studying past and present price action to predict the probability of Japan Tobacco's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Japan Tobacco's price. Additionally, you may evaluate how the addition of Japan Tobacco to your portfolios can decrease your overall portfolio volatility.